
Empatica launched WellPD, an FDA-cleared and CE-marked home-use wrist wearable that tracks tremor, dyskinesia, bradykinesia, sleep, and activity for people with Parkinson’s. WellPD is available in the US, Canada, the UK, Australia and 14 European countries.
Empatica received FDA 510(k) clearance for its Health Monitoring Platform for Parkinson's, its 12th FDA clearance. The system pairs Empatica's clinical-grade wearable with a patient app and clinician portal to continuously track Parkinson's symptoms, including tremor, slowness of movement, involuntary movements, sleep, and medication compliance. It builds on the company's 2025 acquisition of PKG Health, folding PKG's established Parkinson's measures into Empatica's wearable platform.